Talk:Combretastatin
From Wikipedia, the free encyclopedia
Hello I started this page. Combretastatin A-4 is the correct name and the structure is also correct. Combrestatin is incorrect or at the very least a variance of the correct nomenclature. Combretastatin A-4 is part of a larger family of natural products and synthetic analogs. When I search for that CAS number (117048-59-6) I also see Combretastatin A-4 results. Definitely a confusing mistake! Also, the ChemIDplus result for NAME: Combretastatin A-4 RN: 117048-59-6 shows the trans isomer which is technically correct, although the pharmacologically active CA-4 is the cis isomer. Silverweed 07:42, 13 November 2007 (UTC)
Edited the page to reflect a few recent updates, namely that CA-4 has reached its first phase III clinical trial (yay!) and is in numerous phase I and II trials. Check www.clinicaltrials.gov (search for combretastatin) for more info. Silverweed 07:53, 13 November 2007 (UTC)
Is Combretastatin supposed to be on the Statin page? If not (if it's not a statin), maybe that fact should be clarified in this article? Also, if Combretastatin is a statin (which I honestly don't know), then the Statin page should be updated with some information on the anti-cancer effects of Combretastatin. europrobe (talk) 17:29, 28 January 2008 (UTC)
Combretastatin is not a Statin, I'm not sure what the origin of the name is. Silverweed (talk) 11:02, 5 April 2008 (UTC)